Clinical evidence has long suggested that the use of GLP-1 medications is linked to lower substance use. It’s also been speculated among patients taking the medications. Social drinkers, for example, ...
Twenty years after the introduction of the theory, we revisit what it does—and doesn’t—explain. by Clayton M. Christensen, Michael E. Raynor and Rory McDonald Please enjoy this HBR Classic. Clayton M.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results